Long-term monitoring of patients with blood clots
Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study
This study is trying to find out which patients with blood clots need long-term blood-thinning treatment by following them over time and collecting detailed health information.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | China National Center for Cardiovascular Diseases Government |
| Locations | 1 site (Beijing, Beijing) |
| Trial ID | NCT06073366 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a nationwide cohort of patients diagnosed with venous thromboembolism (VTE) to understand which individuals should receive long-term anticoagulation therapy. It will involve yearly follow-ups through various methods such as telephone, hospitalization, or outpatient care. The study will collect comprehensive data, including demographic, clinical, imaging, laboratory, and genetic information, to develop a risk prediction model for VTE recurrence. This model will help clinicians make informed decisions regarding the duration of anticoagulant therapy based on individual risk levels.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with venous thromboembolism.
Not a fit: Patients who are pregnant, lactating, or have an active tumor may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective management of anticoagulation therapy for patients with venous thromboembolism.
How similar studies have performed: Other studies have shown success in developing risk stratification models for VTE, but this specific nationwide cohort approach may provide novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age greater or equal to 18. * Patients diagnosed with venous thromboembolism. Exclusion Criteria: * Pregnant or lactating women * Patients with active tumor
Where this trial is running
Beijing, Beijing
- Chinese Academy of Medical Sciences Fuwai Hospital — Beijing, Beijing, China (Recruiting)
Study contacts
- Principal investigator: Lu Hua — Chinese Academy of Medical Sciences, Fuwai Hospital
- Study coordinator: Tingting Guo
- Email: 18610094559@163.com
- Phone: +86 18610094559
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.